-- Martine A Rothblatt, Director, Chairperson & CEO, on April 07, 2026, sold 9,500 shares in United Therapeutics (UTHR) for $5,358,116. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 679,872 common shares of the company, with 40,513 shares held directly and 639,359 controlled indirectly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1082554/000110657826000028/xslF345X05/primarydocument.xml